share_log

YS Biopharma | SC 13D: Statement of acquisition of beneficial ownership by individuals-Fung Ching Wong(52.23%),Apex Prospect Limited(52.23%)

YS Biopharma | SC 13D: Statement of acquisition of beneficial ownership by individuals-Fung Ching Wong(52.23%),Apex Prospect Limited(52.23%)

YS Biopharma | SC 13D:超過5%持股股東披露文件-Fung Ching Wong(52.23%),Apex Prospect Limited(52.23%)
美股SEC公告 ·  02/14 11:27
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息